The Monopoly Stage of Capitalism

The changes to the current version of the Helsinki Declaration have led to fierce debate, particularly in the pharmaceutical industry and among drug regulators. The new version requires much greater openness: it requires that information about sources of funding or potential conflicts of interests b...

Full description

Saved in:
Bibliographic Details
Published in:The Hastings Center report 2001-05, Vol.31 (3), p.8-8
Main Author: Nicholson, Richard H.
Format: Article
Language:English
Subjects:
American Medical Association
Bioethics
Clinical trials
Clinical Trials as Topic - standards
Helsinki Declaration
Human Experimentation
Human experimentation in medicine
Human medical experimentation
Humans
International aspects
Laws, regulations and rules
Medical ethics
Medical research
Pharmaceutical industry
Self-experimentation in medicine
United States
United States Food and Drug Administration
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The changes to the current version of the Helsinki Declaration have led to fierce debate, particularly in the pharmaceutical industry and among drug regulators. The new version requires much greater openness: it requires that information about sources of funding or potential conflicts of interests be disclosed to IRBs and to subjects, that the design of all studies be publicly available and that the results of all studies be published or otherwise made publicly available, whatever the findings.
ISSN:0093-0334
1552-146X
DOI:10.2307/3527548